Home > News > ANALYSIS: Drugmakers Set High Hopes On Nanotech-Based DDS Drugs
January 24th, 2007
ANALYSIS: Drugmakers Set High Hopes On Nanotech-Based DDS Drugs
Abstract:
The prolonged absence of new drugs on the market reflects the rush by overseas and domestic drugmakers to develop DDS (drug delivery system) technology that uses nanotechnology to deliver existing cancer drugs to patients in capsule form.
On Jan. 4, the Ministry of Health finally approved a cancer treatment that has been available abroad for 12 years. Authorized for the first time here as a treatment for AIDS-related Kaposi's sarcoma, Doxil, a niche drug developed by Janssen Pharmaceutical KK, marks the beginning of nanotech-based DDS drugs in Japan.
Source:
therapeuticsdaily.com
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Human Interest/Art
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||